How Long Till Mounjaro Is Out of Your System

Half-life of approximately five days: tirzepatide's concentration in the body halves roughly every five days after a missed or final dose.
Full clearance in four to five weeks: after around five half-lives, plasma levels fall to clinically negligible levels — typically 25–35 days from the last injection.
Appetite and weight effects can outlast detectable drug levels: physiological changes made during treatment do not disappear the moment the medicine clears.
Timing matters for specific situations: surgery, switching medicines, and trying to conceive all require planning around this clearance window, in discussion with a prescriber.

Tirzepatide (Mounjaro) has a half-life of roughly five days, which means it takes around four to five weeks for it to clear your system entirely after your last injection. That timeline matters whether you are planning surgery, thinking about pregnancy, switching medicines, or simply curious about what happens when you stop. As a prescription-only medicine, any decision about stopping or pausing Mounjaro should be discussed with your prescriber rather than made alone. The sections below walk through exactly how the clearance process unfolds, week by week.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The week-by-week clearance timeline — and what to expect at each stage

Step 1: what happens in the first week after your last injection

Once you miss or take your final dose of Mounjaro, the drug's concentration in your bloodstream begins falling immediately. Tirzepatide's half-life sits at roughly five days, which is unusually long for an injectable medicine. By the end of the first week, levels are noticeably lower but still substantial, roughly half of your last peak concentration remains. You may notice appetite starting to creep back during this window, though most people describe it as gradual rather than sudden. Some mild changes in digestion are common too: the slowing effect Mounjaro has on gastric emptying starts to reverse, which can feel strange after weeks or months of a quieter stomach. There is a common misconception that stopping any injection medicine means it is gone within days, with tirzepatide, that is not the case. If you are curious about how long Mounjaro is actually in your system, the pharmacokinetics are set by the molecule itself, and no amount of extra water or activity speeds the process up meaningfully. The Mounjaro overview page explains how the medicine works in more detail if you want the mechanism behind this.

Step 2: weeks two and three, the slow middle phase

Between around day seven and day twenty-one, plasma tirzepatide continues to decline steadily. Each five-day half-life removes roughly half of whatever remains, so progress is logarithmic: fast at first, then slower. By the end of week two, levels are typically around 25% of the last trough concentration. By the end of week three, you are approaching 10–12%. At this point the physiological effects (appetite suppression, slowed gastric emptying, the dual GIP and GLP-1 receptor signalling) are significantly reduced but not yet absent. This is also the phase where many people notice hunger returning more noticeably. Calorie intake often rises, and without active attention to the dietary habits built during treatment, weight can begin to creep back. Research from the broader SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that participants who stopped tirzepatide regained a portion of lost weight over the following year, underscoring that the drug's presence is doing real physiological work during this phase. If you are switching to a different treatment, your prescriber will use this window to time the transition carefully, and our page on how long until Mounjaro is out of your system can help you understand exactly what that timeline looks like. See the clearance summary page for a condensed version of this schedule.

Step 3: weeks four to five, practical clearance

By day 28–35 after the last injection, tirzepatide is at or below the threshold considered clinically significant. This is the window most commonly used as a planning marker for specific decisions. For surgical procedures, NHS England advises patients to inform their anaesthetist and surgical team that they are taking a GLP-1 medicine, and the residual slowed gastric emptying during this phase is one reason clinicians need advance notice, a full month's notice is commonly requested. For anyone thinking about pregnancy, our detailed guide on how long before Mounjaro is out of your system covers the wash-out period you should allow before trying to conceive; the exact timing should be confirmed with your prescriber, who will also advise on contraception in the interim. The NHS tirzepatide medicines page provides patient-level detail on what to do in these situations. If you are weighing the longer-term cost picture of staying on treatment versus pausing, the Mounjaro cost page gives a factual overview of what private treatment involves financially.

What clearance does not mean for your weight

Here is a practically important point that does not get enough attention: the drug leaving your body does not reset everything you achieved. Muscle retained during treatment, habits built around food, and any improvements in blood sugar or blood pressure may persist well beyond the clearance window, especially if lifestyle changes have become genuinely embedded. What does tend to reverse, for many people, is the suppression of appetite. Hunger-regulating hormones shift back toward pre-treatment patterns fairly quickly once tirzepatide is gone. How quickly, and how pronounced, varies person to person. Some find the return gradual and manageable; for others it is more abrupt. Neither experience is a failure. If you are concerned about what stopping means for your progress, that conversation is worth having before you stop, not after. Our prescribers can talk through your options, including whether a pause or a planned step-down makes more sense than a clean stop. If you have questions about timing, or anything else about your treatment journey, you can also browse the FAQs or reach the team through the contact page. When you are ready to discuss your next steps properly, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions